Printer Friendly

Penetration of milk-derived antimicrobial peptides into phospholipid monolayers as model biomembranes.

1. Introduction

1.1. Structure of Antimicrobial Peptides and Their Action on Pathogenic Cell Membranes. Antimicrobial peptides (AMPs), named also as antibiotic or host defense peptides (HDPs), are evolutionarily conserved components of the innate immune response of a variety of organisms, such as amphibians, invertebrates, plants, and mammals [1]. To date, ca. 2000 different AMPs have been identified or predicted [2, 3]. Many AMPs exhibit a broad spectrum of antimicrobial activity against Gram-positive and Gram-negative bacteria, fungi, parasites, enveloped viruses and cancerous cells [4-7]. In contrast to conventional antibiotics, AMPs appear to be bacteriocidal (bacteria killer) instead of bacteriostatic (bacteria growth inhibitor). They can destroy bacteria within minutes with the rate being faster than the bacteria growth rate [8]. Therefore, AMPs are recognized as potent source of pharmaceuticals for the treatments of multidrug-resistant microorganisms [1-21]. To date, several AMPs are in clinical trials [1, 5, 22]. Interest in AMPs is being constantly increasing during the last ten years which resulted in a number of publications on structure, bioactivity and mechanisms of action of particular AMPs on microbial or model cell membranes. These investigations are reviewed in a number of articles [2,4-21].

AMPs show an extraordinary structural diversity of primary and secondary structure, and the latter is often different in solutions and lipidic environment [20, 22, 23]. AMPs mostly range between 10 and 40 [3, 8] of amino acid residues (although there are shorter or larger peptides classified as AMPs). Most of the AMPs share two common fundamental features--they are cationic and amphiphatic [2, 11-13]. The cationic charge is contributed by positive amino acids (arginine, lysine, and also--in acidic environment--histidine) from 2 to 9 per peptide molecule [2, 3]. The crucial property of AMPs' structure is a large proportion of hydrophobic amino acid residues ([greater than or equal to] 30% [2]) which are spatially organized in discrete sectors of the molecule, making it amphiphatic. The key property of AMPs is selective toxicity to microbial or cancerous cell membranes with no significant toxicity to native (host) cells. The selectivity is driven by a different charge of outer leaflet of microbial (negative) and mammalian/plant (neutral) cell membranes [1,5,6,8,11]. The increase in hydrophobicity of AMP is strongly correlated with alossofitsselectivity 11].

There is no common molecular mechanism of action of AMPs--it depends on the nature of the peptide, the membrane lipid composition and the peptide/lipid ratio [1, 2, 8, 11]. The mechanism comprises several stages which are not yet fully understood, despite extensive studies. The necessary step is peptide's association with membrane lipids which results in long-range defects. The different molecular mechanisms postulated (such as barrel-stave or toroidal/wormhole pore formation, aggregate channel formation or surfactantlike interactions [1, 2, 8, 11-14, 16, 19]) assume that aggregation/oligomerization of AMP in the cytoplasmic membrane is the necessary step leading to the membrane lysis.

1.2. Milk-Derived AMPs. Antibacterial properties of milk have been known for a long time. Bovine milk proteins are a natural reservoir of bioactive peptides which are released during gastrointestinal digestion of milk or its fermented products. So far, several peptides released from milk proteins have been recognized as having a wide spectrum of antimicrobial activities [24-35]. These AMPs are regarded as nontoxic for mammalian cells; therefore, they are considered as potent drugs, food biopreservatives, and/or supplements in functional foods [35]. Interest in milk AMPs is constantly growing. Those derived from the major milk proteins (caseins, [alpha]-lactalbumin, and [beta]-lactoglobulin) have been recently reviewed in [35]. The most often investigated milk-derived AMP is so far bovine lactoferricin (LfcinB), originally derived from lactoferrin (the minor milk protein) as 25 aminoacid peptide [36-39]. LfcinB shows an extraordinarily broad range of bioactivities, including antibacterial, antifungal, antiparasitic, and anticancerous [39]. Much less is known on other milk-derived AMPs. One of the most promising of them is lactophoricin-I which of structure (primary and secondary) is completely different from lactoferricin B (LfcinB). Lactophoricin-I is announced as the first AMP derived from lactophorin [32]--the minor milk protein. Although, there are several reports on lactophoricin-I, describing its production [32, 33, 40], structure [32-34], 40, 41], and interactions with model biomembranes, (such as supported lipid bilayers [33] and micelles [41], as well as antimicrobial activities in vitro [32, 41]), further investigations on this peptide and other milk-derived AMPs are required to recognize their potential applications.

1.3. Studies of AMP Interactions with Phospholipid Monolayers. Phospholipid monolayer spread at the air/aqueous solution interface is considered as a halfmembrane and recommended as the simplest model of cell membrane [4245]. Lateral pressure (n) of biomembranes is put forward in the range of 30-35 mN/m [46, 47], although, owing to different lipid compositions of various biomembranes, their pressure may fall in the lower range, n > 20 mN/m. It is thought that the density range of biomembranes corresponds to mixture of liquid expanded (LE) and liquid condensed (LC) phospholipid phases or to a LC phase.

The monolayer model of biomembrane enables overcoming some serious limitations created by the more advanced models [44], such as phospholipid unilamellar vesicles (SUV or LUV) creating theoretical problems with their surface curvature, or supported phospholipid bilayers which of structures are strongly influenced by the support. The monolayer model is convenient for investigations on initial peptide-lipid interactions involving peptide's association to lipid head groups which is followed by a partial embedding in the hydrophobic region; these stages are found sufficient for antimicrobial action of numerous AMPs.

There is a number of papers in which kinetics of AMP association with phospholipid monolayers was investigated under stationary diffusion conditions to acquire the so-called penetration profiles of the surface pressure, [DELTA][PI] versus [[PI].sub.init] [48-53]. Increase of the surface pressure, [DELTA][PI], upon the penetration process is attributed to compression of the lipid component owing to the amphiphile's insertion [46]. The penetration profiles, [DELTA][PI] versus [[PI].sub.init], of numerous AMPs are found linear [48-51], likewise those measured for insertion of bioactive peptides and proteins [47, 54, 55]. Linearity of the [DELTA][PI] versus [[PI].sub.init] profiles is attributed to linear increase of the surface pressure with mole fraction of the inserted amphiphile--the dependency is valid only for low amphiphile concentrations [46]. On the other hand, also nonlinear [DELTA][PI] versus [[PI].sub.nit] profiles have been reported for some AMPs [52, 53] or bioactive peptides [47, 56-58]. Interpretation of the profiles is complicated by the fact that the surface pressure may change with degree of peptide insertion [46] or with 2D phase composition of the monolayer [47]. Investigations on stationary penetration of AMPs are most often combined with compression isotherms of pure peptide and peptide-lipid mixed monolayers [59, 60].

In the present work, three antimicrobial bovine milk-derived peptides called E-5-K, L-16-Y, and N-23-T (the names formed of symbols of the first and the last aminoacid residue and their total number) were tested with respect to penetration to insoluble monolayers formed with 1,2-dipalmitoylsn-glycero-3-phosphocholine (DPPC) or 1,2-dipalmitoyl-snglycero-3-phospho-rac-(1-glycerol) sodium salt (DPPG). The two type monolayers of well-documented properties (DPPC [61-64], DPPG [62, 65-71]) serve us as crude model of mammalian (neutral) and bacteria (negative) cell membranes, respectively. The most promising of the investigated peptides is N-23-T, recently named lactophoricin-I [32, 40, 41]. It shows an amphiphatic structure [40, 41] and a range of antimicrobial activities [32]. The two other milk AMPs were chosen with respect to their different charge as compared to N-23-T (cf. Table 1).

The main purpose of this investigation is to characterize the molecular interactions in terms of the surface pressure, n, and the electric surface potential, [DELTA]V. The [PI] measurement supplies the direct information on free energy of interactions between lipid monolayer and the penetrant. The surface potential measurement, scarcely used, so far, in investigation of AMPs' penetration into lipid monolayers [72-74], supplies information on state of ordering the monolayer. The effects on [PI] and [DELTA]V upon the peptides' penetration were examined under stationary diffusion conditions in relation to: (1) the initial density of phospholipid monolayer characterized by the equilibrium surface pressure, [[PI].sub.init], (2) type of phospholipid (DPPC or DPPG) and (3) the peptide's concentration. The [DELTA][PI] and [DELTA]V effects upon the penetrant's association with the film are discussed in terms of mutual interactions and disordering the monolayer. Dependence of the penetration effects on the film density is discussed in terms of fit ability of the penetrant's amphiphatic structure to density of phospholipid monolayer. For lactophoricin-I, compression isotherms ([PI]-A and [DELTA]V-A) on subphase containing this peptide are also discussed. The investigations are focused on verifying whether the [PI] and [DELTA]V effects measured upon compression of the lipid monolayer on subphase containing the penetrant differ from those obtained under stationary diffusion conditions.

2. Materials and Methods

2.1. Materials. 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC, [greater than or equal to] 99%) and 1,2-dipalmitoyl-sn-glycero-3-phosphorac-(l-glycerol) sodium salt (DPPG, 99%) were from Sigma. The peptides were originally isolated from the sequence of bovine milk proteins: 5 residues peptide from [alpha]-lactalbumin was named E-5-K, 16 residues peptide from [alpha]-s2 casein was named L-16-Y, and 23 residues peptide from component-3 of proteose peptone (PP3) was named N-23-T or lactophoricin-I [32] (the latter is alternatively denoted in the literature as LPcin-I [40, 41]). More information on synthesis and purification of these peptides is given in [32, 33, 75] and on the structure and antimicrobial activities in vitro in [26, 31-34]. The available data on physicochemical properties of the peptides are comprised in Table 1. The net charge predicted using the "Peptide Property Calculator" software of CS Bio Co. for E-5-K is 0 in the pH range of 5.5-8, for L-16-Y is +4 in the pH range of 4-8, and for N-23-T is +2.1 in the pH range of 7-8, while under the used pH of 5.6 it adopts the value of +3.

The used Milli-Q water was of the electric conductivity (in contact with C[O.sub.2]) of ca. 0.8 [micro]S/cm and of the surface tension of 72.8 mN [m.sup.-1]. The phospholipid stock solutions were prepared with spectrophotometric grade chloroform (Aldrich, A.C.S.).

2.2. The Penetration Measurement under Stationary Diffusion Conditions. These measurements were performed in a Petri dish of inner diameter of 2r = 9.5 cm. Since the peptides were available in small amounts, the subphase volume was minimized to 20 mL. The measurement procedure was as follows. Phospholipid monolayer was spread at the air/water interface from ca. 1 mg/mL DPPC or DPPG solution in 10% ethanol in C[Cl.sub.4] (using a Hamilton syringe) up to reaching the desired surface pressure, [[PI].sub.init], established after ca. 10 min. equilibration of the film. Next, aqueous peptide solution (100-1000 [micro]L) was injected beneath the phospholipid monolayer to adjust the peptide's desired concentration in the range of 5 x [10.sup.-7-1] x [10.sup.-5] mol [dm.sup.-3]. The crucial step of these experiments was averaging peptide's concentration just after its injection, performed on the way securing against a disturbance of the phospholipid film. It was achieved by means of a glass stirrer (mounted at the bottom of the cell) which was put rotated during ca. 5 s after the injection. Next, the penetration process was investigated by measuring time evolution of surface pressure, [PI]-t, and electric surface potential, [DELTA]V-t, during 60 min.

The surface pressure (n) and the electric surface potential ([DELTA]H) measurements were performed using the KSV 5000 Langmuir balance and the KSV 1000 SPD surface potential meter (KSV Ltd., Helsinki). The surface pressure (n) was measured with a platinum Wilhelmy plate (perimeter 3.94 cm) and the electric surface potential ([DELTA]V) with a gold plated vibrating plate (VP)--not perforated. The counter electrode for the [DELTA]V measurement was a silver, silver chloride half cell (Ag, AgCl/3 M KCl) manufactured by the Radiometer firm. The measuring sensors and the cell were placed together in a Plexiglas box thermostated at 20[degrees]C.

2.3. The Compression Isotherms, [PI]-A and [DELTA]V-A. A Teflon trough (15 cm x 58 cm x 1 cm) with two hydrophilic Delrin barriers (symmetric compression) was used in compression isotherm experiments. The system was equipped with an electrobalance and a platinum Wilhelmy plate (perimeter 3.94 cm) as the surface pressure sensor. Surface potential was measured using the KSV Spot 1 with the gold plated vibrating plate. The counter electrode for the measurement--supplied by the producer--was made of a stainless steel. The apparatus was closed in a Plexiglas box thermostated at 20[degrees]C. All solvents used for cleaning the trough and the barriers were of analytical grade. Calibrated solutions of DPPC and DPPG in chloroform (concentration around 0.5 mg [mL.sup.-1]) were used for spreading (with a microsyringe of Hamilton Co., USA) lipid monolayers on the peptide's solution subphase. After the equilibration time of 20 min, the films were compressed at the rate of 2.5 mm [min.sup.-1] [barrier.sup.-1] by two symmetrically moving barriers. A PC computer and KSV software were used to control the experiments. Each compression isotherm was performed at least three times. The standard error was [+ or -] 0.5 [[Angstrom].sup.2] with mean molecular area, [+ or -] 0.2 mN [m.sup.-1] with surface pressure, and [+ or -] 5 mV with surface potential measurements.

3. Results and Discussion

3.1. Surface Activity of the Milk-Derived Peptides at the Air/Water Interface. Activity of the peptides at the air/water interface was investigated by injecting an amount of the original peptide's solution into water sample to reach the desired concentration after stirring. It was found that the only one of the peptides, lactophoricin-I (N-23-T), increases significantly the surface pressure at the air/solution interface; that is, solutions of 1 x [10.sup.-6], 5 x [10.sup.-6] and 1 x [10.sup.-5] mol N-23-T [dm.sup.-3] showed the equilibrium surface pressure of 12.2, 16.7, and 19.5 mN [m.sup.-1], respectively, and about 90% of the n values were established during 30 min after the peptide injection. Lactophoricin-I produced also a high change of the electric surface potential, [DELTA]V, which increased between 400 and 1100 mV, depending on the concentration. In contrast, L-16-Y and E-5-K peptides did not show surface activity at the air/solution interface (i.e., n in the range between -2.5 and +0.5 mN [m.sup.-1] and [DELTA]V in the range of 100-600 mV were measured at their concentrations in the range of 1 x [10.sup.-6]-1 x [10.sup.-5] mol [dm.sup.-3]). Noteworthy, the surface potential of the nearly neutral peptide E-5-K started at a slightly negative value in the range of -200 to -50 mV (depending on the concentration) and increased by ca. 300 mV during 60 min. The surface activity of N-23-T at the air/solution interface (in contrast to L-16-Y and E-5-K) should be ascribed to the relatively greatest amount of hydrophobic residues in the peptide chain and in particular to situating all of them in outer sphere of the molecule (cf. Table 1).

3.2. Compression Isotherms of DPPC and DPPG Monolayers on Lactophoricin Containing Subphase. The surface pressure versus area ([PI]-A) and electric surface potential versus area ([DELTA]V-A) isotherms registered upon compression of DPPC and DPPG monolayers on pure water and the subphase containing 1 x [10.sup.-6] mol [dm.sup.-3] lactophoricin-I are shown in Figures 1(a) and 1(b).

One may notice in Figures 1(a) and 1(b) the huge expanding effect exerted by lactophoricin-I both on DPPC and DPPG monolayers. The percentage increase of area per the phospholipid molecule, [DELTA]A/A, upon the peptide insertion is presented in Figure 2 as a function of n. These [DELTA]A/A versus [PI] dependencies were evaluated from the isotherms registered on the peptide containing subphase and pure water by comparing areas at identical [PI] values. Note that the expansion exerted by lactophoricin-I on DPPG monolayer (by ca. 800%) is about twice greater than that on DPPC, indicating that electrostatic interactions of the positively charged peptide with negatively charged phosphoglycerol groups drag more peptide into the monolayer as compared to neutral DPPC. On the other hand, a great expansion of DPPC monolayer by the peptide (by ca. 400%) indicates competitive adsorption of N23-T at the air/water interface (cf. Section 3.1). The adsorbed peptide, owing to its notable charge, may form highly spread 2D domains (Table 1). Taking the above in mind, the 10 < n < 20 mN [m.sup.-1] range corresponding to the maximum expanding effect is to be ascribed to the coexistence of 2D peptide domains with 2D phospholipid domains, LC. The latter may be to an extent perturbed by the peptide-lipid interactions, in particular in case of DPPG monolayer for which, also, formation of a mixed lipid-peptide 2D phase cannot be excluded. In the higher [PI] range, 20 < [PI] < 35 mN [m.sup.-1], the expanding effect is steeply falling down to near zero which indicates collapse of the peptide's domains in the n range. Noteworthy, the [PI]-A isotherms obtained by us for the DPPC- and DPPG-lactophoricin-I systems show a great analogy to those presented by Neville and coworkers [76, 77] for the penetration of cathelicidin peptide, LL37, into DPPC and DPPG monolayers. Interestingly, the isobaric insertion experiments ([DELTA]A/A versus time measurements) [77] revealed a notable expanding effect of LL37 on DPPG (up to ca. 180%) which was not revealed, at all, for the DPPC/LL37 system, although the [PI]-A isotherm indicates it. The discrimination effect of LL37 in favour of the negative monolayer is supported by the results of the concurrent measurements using epifluorescence microscopy [77] and surface synchrotron X-ray scattering [76, 77] techniques which showed a great (progressing with time) structural change of DPPG monolayer upon LL37 penetration, opposite to DPPC monolayer; the latter did not show any significant structural change in contact with LL37 The authors [76] postulate the formation of a mixed DPPG-LL37 2D phase which undergoes an extra 2D phase transition indicated by a flat hump in the n-A isotherm. There are, however, no other pieces of evidence for the formation of a mixed phase in the DPPG/LL37 or DPPG/lactophoricin systems, so far.

Figure 3 shows the penetration effects calculated by comparing the [PI] and [DELTA]V ordinates of the isotherms registered in the presence and absence of the penetrant, respectively. The [DELTA][PI] and [DELTA][DELTA]V differences at the same A areas are displayed as a function of the surface pressure of the pure phospholipid monolayer, [[PI].sub.lipid]. The [DELTA][pi] versus [[PI].sub.lipid] dependencies shown in Figure 3 are counterparts of the so-called penetration profiles measured under stationary diffusion conditions as the surface pressure increases, [[DELTA].sub.[pi]], as a function of the initial n value. However, it should be stressed here that the profiles derived from the compression isotherms correspond to squeezing penetrant out of the monolayer, opposite to the profiles measured directly upon the penetration process under stationary diffusion conditions. One may notice in Figure 3 that the maximum [DELTA][PI] effects determined for DPPC/N-23-T and DPPG/N-23-T systems are comparable, amounting to 32 and 34 mN [m.sup.-1], respectively. The [[DELTA].sub.[PI]] effect decreases with increasing the lipid density, reaching the minimum (of ca. -1 mN [m.sup.-1] for the DPPC/N-23-T system and ca. 6 mN [m.sup.-1] for the DPPG/N-23-T) close to the collapse point. The [DELTA][PI] versus [[PI].sub.lipid] dependencies presented in Figure 3 show a slight departure of linearity, a greater one for the DPPG/N-23-T than for DPPC/N-23-T system. The positive in sign [DELTA][PI] effects within almost entire compression range indicates the excess attractive interactions of the both lipids with the penetrant. The corresponding [DELTA][DELTA]V versus [[PI].sub.lipid] dependencies show much greater differentiation with respect to the phospholipid type as compared to the [DELTA][PI] versus [[PI].sub.lipid] (Figure 3). The [DELTA][DELTA]V versus [[PI].sub.init] dependencies decline within the entire compression range and in majority of it adopt values negative in sign. The [DELTA][DELTA]V minimum reached close to the collapse point is ca. -200 mV for the DPPC/N-23-T system and ca. -20 mV for DPPG/N-23-T. The positive [DELTA][DELTA]V effects are measured only within the lowest density range of n < 3 mN [m.sup.-1] in which DPPC and DPPG monolayers are highly expanded by the peptide (i.e., ca. 3 times in case of DPPC and ca. 8 times in case of DPPG). Such expansion allows for orientational freedom of the lipids. Accordingly, the higher expansion of DPPG monolayer, as compared to DPPC, is accompanied by the much less negative [DELTA][DELTA]V effect. Since the net negative [DELTA][DELTA]V effect is caused by the positively charged peptide, it is attributed to disorienting acyl chains of the phospholipid by the penetrant. This explanation is in accord with the commonly accepted view [78-80] that decrease in inclination of hydrocarbon chains with respect to the interface diminishes their contribution to the surface potential [80].

Inserts in Figures 1(a) and 1(b) show courses of the compressibility modulus, [C.sup.-1.sub.s], defined as [81, 82]

[C.sup.-1.sub.s] = -A[([partial derivative][PI]/[partial derivative]A).sub.T] (1)

calculated from the n-A isotherms. According to Davies and Rideal [81], value of [C.sup.-1.sub.s] is indicative of 2D phase composition; namely, the range of 12.5 < [C.sup.-1.sub.s] < 50 mN [m.sup.-1] corresponds to liquid expanded phase (LE, chain disordered) and of 100 < [C.sup.-1.sub.s] < 250 mN [m.sup.-1], to liquid condensed phase (LC, chain ordered); (some authors [58] distinguish also the intermediate range of 50 < [C.sup.-1.sub.s] < 100 mN [m.sup.-1] ascribed to the L1 phase). Increase in [C.sup.-1.sub.s] corresponds to increase of rigidity (i.e., decrease of compressibility) of the monolayer [82]. The [C.sup.-1.sub.s] versus n courses of DPPC monolayers (insert of Figure 1(a)) shows consistently local maximum at n ca. 2.5 mN [m.sup.-1] which is ascribed by us to the maximum density of LE-DPPC phase. The following minimum [C.sup.-1.sub.s] versus [PI] within the 3 < [PI] < 7 mN [m.sup.-1] range is ascribed to coexistence of LE and LC phases of DPPC. In the range corresponding to the greatest expansion exerted by lactophoricin-I on the phospholipid monolayers, 8 < [PI] < 20 mN [m.sup.-1] (cf. Figure 2), the [C.sup.-1.sub.s] versus [PI] dependency of the penetrated DPPC monolayer shows a slightly greater rigidity as compared to pure DPPC monolayer. It indicates the peptide's interactions with LC phase of DPPC. Just the opposite occurs within the 20 < [PI] < 35 mN [m.sup.-1] range corresponding to the fall down of the expanding effect (cf. Figure 2); that is, the [C.sup.-1.sub.s] versus n successively falls down to the minimum of ca. 2 mN [m.sup.-1] at [PI] ca. 31 mN [m.sup.-1] that the minimum reflects the inflection point in the [PI]-A isotherm of the penetrated DPPC monolayer within the wide plateau region. The latter indicates a 2D phase transition (or possibly two consecutive ones) which may be ascribed to the peptide itself and, possibly, to a mixed peptide-lipid 2D phase. This hypothesis is based on the fact that monolayers of many AMPs on water subphase show a 2D transition in the 20 < [PI] < 30 mN [m.sup.-1] range and collapse at n ca. 30 mN [m.sup.-1] [44, 49]. Collapse of DPPC monolayer on water subphase and 1 x [10.sup.-6] mol [dm.sup.-3] lactophoricin-I solution occurs at n values of 55.2 and 55.1 mN [m.sup.-1], respectively, which correspond to the areas of 40 and 42 [[Angstrom].sup.2] per lipid molecule [75]. These parameters indicate that lactophoricin-I has been squeezed from the monolayer before its collapse. A slight difference in the corresponding [C.sup.-1.sub.s] versus n dependencies within the 45 < [PI] < 52 mN [m.sup.-1] range implies very slight interactions of phophocholine groups with the squeezed peptide.

Courses of the [C.sup.-1.sub.s] versus [PI] dependencies calculated for DPPG monolayers (insert of Figure 1(b)) not only significantly differ from that for DPPC but also show a wide minimum within the 20 < [PI] < 35 mN [m.sup.-1] range which is ascribed to squeezing the penetrant out of the monolayer (cf. Figure 2). The [C.sup.-1.sub.s] values close to zero in this range indicate enormously great compressibility (fluidity) of the monolayer as the result of squeezing the peptide's domains. Since pure DPPG monolayer does not show LE/LC phases coexistence at pH ca. 5.6, at 20[degrees]C [65, 66], its [C.sup.-1.sub.s] increases successively from zero to the maximum of ca. 500 mN [m.sup.-1] ascribed to the 2D solid (S). Interestingly, in the range of the highest expansion of DPPG monolayer by lactophoricin-I, 8 < [PI] < 20 mN [m.sup.-1] (cf. Figure 2), the penetrated monolayer shows local [C.sup.-1.sub.s] versus n maximum of ca. 210 mN [m.sup.-1]. It may be ascribed to LC-DPPG phase perturbed by the peptide. Just the opposite occurs in the range of falling down the expansion effect, 20 < [PI] < 35 mN [m.sup.-1], wherein the [C.sup.-1.sub.s] versus n dependency shows the wide minimum of significantly different shape as compared to that of DPPC (Figure 1(b)). The collapse point of DPPG monolayers on water subphase and lactophoricin-I solution falls at the notably different n values, of 53.1 and 58.1 mN [m.sup.-1], corresponding to 40 [[Angstrom].sup.2] and 41A2 per molecule, respectively [75]. These parameters indicate notable interactions of phosphoglyceride groups with lactophoricin-I squeezed into the subsurface region. These interactions are revealed also in shape of the [C.sup.-1.sub.s] [PI] dependencies within the 40 < [PI] < 50 mN [m.sup.-1] range, by notable lowering of [C.sup.-1.sub.s] value of the penetrated DPPG monolayer relative to pure DPPG, that is, the decrease of [C.sup.-1.sub.s] from ca. 500 to ca. 200 mN [m.sup.-1] (c.f., Figure 1(b)) reflecting a significant increase of the monolayer's fluidity (i.e., softening the monolayer owing to interactions with the squeezed peptide). Since, the [C.sup.-1.sub.s] value of 200 mN [m.sup.-1] is typical of a liquid condensed 2D phase [81], we conclude that presence of the squeezed peptide does not allow for formation of 2D solid phase of DPPG. A more detailed explanation of the peptide-lipid interactions requires further investigations with applying structural techniques applicable to monolayers.

3.3. Time Evolution of Stationary Penetration Effects, An versus t and [DELTA][DELTA]V versus t. Changes in the surface pressure (n) and the electric surface potential ([DELTA]V) during stationary penetration of N-23-T peptide into DPPC or DPPG monolayers are compared in Figures 4(a), 4(b), 5(a), and 5(b), respectively.

One may see that stationary penetration of N-23-T into DPPC monolayers causes a negligible [DELTA][PI] effect (Figures 4(a) and 6(a)), in contrast with that found from the compression isotherms (Figure 3). The small negative [DELTA][PI] effects (of ca. -2.5 mN [m.sup.-1], at maximum) were also measured during stationary penetration of the other peptides to DPPC monolayer. They indicate that the penetrants weaken lateral DPPC-DPPC interactions. The [DELTA][DELTA]V-t courses measured for the DPPC/N-23-T system (Figure 4(b)) show a decrease of the [DELTA]V up to ca. -1000 mV; the slightly less [DELTA][DELTA]V-t decrease (by ca. -600 mV) was measured for the DPPC/L-16Y system (results not shown). The negative [DELTA][DELTA]V effect implies disorienting DPPC monolayer.

The [DELTA][PI] effects of the stationary penetration of the positively charged peptides to negatively charged DPPG monolayer (Figure 5(a)) are much greater as compared to DPPC; the maximum [DELTA][PI] effect amounts to 14 mN [m.sup.-1] for N-23-T (Figure 5(a)) and 8 mN [m.sup.-1] for L-16-Y (Figure 7(a)). These [DELTA][PI] effects fall within the range reported by other authors for penetration of various AMPs to monolayers of different phospholipids [48-50, 52, 53]. It should be emphasized here that affinities of N-23-T and L-16-Y for DPPG monolayer are comparable, despite the fact that N-23-T shows surface activity at the air/water interface, opposite to L-16-Y. (cf. Section 3.1). It is reasoned by the fact, that, most of AMPs in a lipidic environment adopt an amphiphatic conformation which may be greatly different from that in the solution bulk [2, 11-19], as it was proven by circular dichroism (CD) and nuclear magnetic resonance (NMR) investigations [22, 23] (cf. Table 1). The less negative effect of N-23-T on [DELTA][PI] of DPPG monolayer, as compared to DPPC, is ascribed by us to the attractive, electrostatic peptide-DPPG interactions which drag the positive peptide into the monolayer on a greater depth.

3.4. Effects of Stationary Penetration as a Function of Phospholipid Density. The [DELTA][PI] and [DELTA][DELTA]V effects of stationary penetration of L-16-Y and N-23-T peptides to DPPC and DpPG monolayers, measured after the contact time of 60 min., are compared in Figures 6(a), 6(b), 7(a), and 7(b), as a function of the initial surface pressure of the monolayer, [[PI].sub.init].

It should be mentioned here that the hazardous step of the stationary penetration measurements (as mentioned in Section 2) is equalization of the penetrant's concentration immediately after injection, which may cause a disturbance of the phospholipid monolayer. On the other hand, manual operations in vicinity of the VP made vibrate may cause an uncontrolled shift in the apparatus zero level. (The vibrating plate technique is known of numerous interferences discussed by us in detail in [83]). Having the above in mind, the initial [DELTA]V values against which the [DELTA][DELTA]V effect was evaluated were taken just after finishing stirring the solution below the monolayer. The [DELTA][DELTA]V effects evaluated on this way contain the [DELTA]V-t evolution as a result of the preceding penetration, not including a stepwise change observed in some experiments during injection of peptide and equalization of its concentration. This mode of calculating the [DELTA][DELTA]V effect assures the less as possible experimental error resulting only from accuracy of the [DELTA]V measurement itself, [+ or -] 10 mV, at maximum; this error shown by vertical error bars in Figures 6(b) and 7(b) falls within the used marks. The maximum error in determining [[PI].sub.init] values (taking into account the n change during equilibration of the pure phospholipid monolayer and equalization of the peptide's concentration) was [+ or -] 0.3 mN [m.sup.-1]. Since the error in determining [[PI].sub.init] values affects the [DELTA][PI] = n - [[PI].sub.init] dependence, the lateral and vertical error bars shown in Figures 6(b) and 7(b) are identical. As one can see in Figures 6(b) and 7(b), the experimental errors fall within the used marks with the exception of Figure 6(a).

The results presented in Figures 6(a) and 7(a) indicate nonlinearity of the [DELTA][PI] versus [[PI].sub.init] dependencies, called the penetration profiles [56]. One can see that the [DELTA][PI] versus [[PI].sub.init] profiles (Figures 6(a) and 7(a)) and the corresponding [DELTA][DELTA]V versus [[PI].sub.init] dependencies (Figures 6(b) and 7(b)) show local extrema which of position on the [[PI].sub.init] axis depends on the phospholipid type. The extrema suggest a dependence of the penetration effects on 2D phase composition of the monolayer and, possibly, on shape and dispersion degree of the 2D phases' domains. Even though a number of authors have presented linear [DELTA][PI] versus [[PI].sub.init] profiles for penetration of numerous AMPs [48-52] or bioactive peptides [47, 54, 55] to phospholipidmonolayers, some other results suggest that linearity of [DELTA][PI] versus [[PI].sub.init] is not the rule for all peptides [52, 53, 56-58]. For instance, Weronski and coworkers [58] obtained nonlinear [DELTA][PI] versus [[PI].sub.init] dependencies for penetration of synthetic decapeptides (being a fragment of the nonstructural hepatitis G NS3 protein) to DPPC and DPPG monolayers. The profiles are of similar shape to those presented by us and show similar differentiation between DPPC and DPPG monolayers. Another example of [DELTA][PI] versus [[PI].sub.init] profiles transferring throughout maximum is given in [56] for penetration of annexin-V to phospholipid monolayers formed with phosphocholine (POPC), phosphoglycerol (POPG), and phosphatidylserine (POPS), or their mixtures. On the other hand, a departure of some measuring points from the fitted linear dependence, [DELTA][PI] versus [[PI].sub.init], [57] suggests a more complex course than the linear.

It is worth mentioning here that linear [DELTA][PI] versus [[PI].sub.init] profiles presented in the literature for AMPs and bioactive peptides are mostly measured in range of [[PI].sub.init] below 30 mN [m.sup.-1] [44, 49, 58] or much narrower [47, 54, 57]. In general, the linear [DELTA][PI] versus [[PI].sub.init] profiles are used for determination of the so-called maximum insertion pressure (MIP) [47] (named also as the exclusion surface pressure) which is the extrapolated [[PI].sub.init] value at which no effect on the surface pressure occurs ([DELTA][PI] = 0). This interpretation assumes that above the MIP no insertion of the peptide into the monolayer occurs. Since MIP values were usually found close to [[PI].sub.init] of 30 mN [m.sup.-1] or less (while biomembranes are expected to show n in the range of 30-35 mN [m.sup.-1] [46, 47]), one could conclude from the results no ability of numerous AMPs to penetrate bacteria membranes in contrast to the documented antibacterial activities in vitro. Despite the fact that MIP values are useful for assessing potent interactions of bioactive peptides with biomembranes, one cannot directly refer them to penetration into phospholipid bilayers or bacteria membranes--the more advanced biomembrane model than a phospholipid monolayer. The other question concerning MIP was discussed by Barnes and coworkers [84, 85] who showed that some amphiphiles may exist in condensed Langmuir monolayers above MIP, on account for a high energy barrier of their ejection upon compression. The above mentioned ambiguities concerning MIP imply that a phospholipid monolayer upon compression (or decompression) does not reproduce all biomembrane properties determining penetration of AMPs. Nevertheless, the monolayer model of biomembranes is useful for investigating AMP-lipid interactions at initial stages of penetration under stationary diffusion conditions.

The profiles shown in Figures 6(a), 6(b), 7(a), and 7(b) let us follow conveniently sign of the [DELTA][PI] and [DELTA][DELTA]V effects in the particular systems. The stationary penetration to DPPC monolayers results in the [DELTA][PI] and [DELTA][DELTA]V effects negative in sign within almost the entire investigated [[PI].sub.init] range (Figures 6(a) and 6(b)). These [DELTA][PI] versus [[PI].sub.init] profiles (Figure 6(a)) show a plateau in the [[PI].sub.init] range above 30 mN [m.sup.-1], consistently for the two positively charged peptides, N-23-T and L-16-Y. This plateau implies reaching maximum of the low peptide interactions with DPPC monolayer. Simultaneously, the electric surface potential, [DELTA]V, of DPPC monolayer is strongly lowered by the positively charged peptides, in particular at [[PI].sub.init] of ca. 30 mN [m.sup.-1] (Figure 6(b)) which coincides with the greatest fluidity indicated by the [C.sup.-1.sub.s] versus n minimum (insert of Figure 1(a)).

On the other hand, stationary penetration of the positively charged peptides into DPPG monolayers produces [DELTA][PI] effects positive in sign within almost entire investigated range of [[PI].sub.init] (Figure 7(a)), while the corresponding [DELTA][DELTA]V effect shows reversal in sign along the [[PI].sub.init] axis (Figure 7(b)). The [DELTA][PI] versus [[PI].sub.init] dependencies measured for the stationary penetration into DPPG monolayer (Figure 7(a)) show a narrow maximum at [[PI].sub.init] of ca. 24 mN [m.sup.-1] which falls in the range of LC phase of pure DPPG monolayer (for discussion of 2D phase transitions in DPPG monolayers, see [62,67-71]). The maximum [DELTA][PI] effect indicates the maximum peptide-DPPG monolayer interactions in terms of lowering the surface free energy (the [PI] increase).

Notice that the total surface pressure of the discussed maximum, [[PI].sub.init] + [DELTA][PI] = ca. 38 mN [m.sup.-1], falls close to the range typical of real biomembranes and, on the other hand, within the region ascribed to the subsurface peptide-lipid interactions (cf. Figure 1(b)). The [DELTA][DELTA]V maxima, occurring consistently at the same [[PI].sub.init] value as the [DELTA][PI] maxima, suggest the best structural peptide-lipid adjustment (in terms of ordering molecular groups' dipoles which of greater inclinations to the interface contribute greater partial drops to the [DELTA]V). Notice that the positive [DELTA][DELTA]V effect prevails for N-23-T of the charge +3, while the negative [DELTA][DELTA]V prevails for L-16-Y of the charge +4 (Figure 7(b)). It indicates that the positive [DELTA][DELTA]V effect is not predominantly driven by the peptide's cationic charge. Even more, the greater cationic charge seems to cause a greater disorientation of DPPG monolayer as revealed by the greater lowering of the [DELTA]V (Figure 7(b)). It may be explained by increasing depth of the penetration due to the stronger electrostatic interactions. The results of Figures 7(a) and 7(b) indicate that when DPPG density increases above that at which the [DELTA][PI] versus [[PI].sub.init] maximum shows, both the specific interactions (indicated by [DELTA][PI]) and structural fit ability of the peptide to DPPG monolayer (indicated by the [DELTA][DELTA]V) diminish. These changes maybe ascribed to decreasing depth of the peptide's penetration, followed by reorientation of phosphoglycerol groups.

3.5. Comparison between Stationary Penetration Effects and Those Evaluated from Compression Isotherms. It should be emphasized here that magnitude of the [DELTA][PI] effects determined from the stationary penetration experiments (Figures 6(a) and 7(a)) differs notably from that evaluated from the compression isotherms (Figure 3). The difference is shown in particular for DPPC monolayer, for which the stationary penetration effect [DELTA][PI] is negligible (of ca. -1 mN [m.sup.-1], Figure 6(a)), while that evaluated from the compression isotherm is greater by order of magnitude (Figure 3). On the other hand, the stationary [DELTA][DELTA]V effect reaches the maximum in the range of-500 and -1000 mV (Figure 6(b)), while that evaluated from the compression isotherms changes in the range between 30 and ca. -200 mV (Figure 3). The negligible [DELTA][PI] effect obtained for the stationary penetration into DPPC monolayer coincides with a very low hemolytic activity (i.e., a negative effect on red blood cells, RBC) of N-23-T and L-16-Y. Comparing the data compiled in Table 1, one can see that N-23-T does not show hemolytic activity (which was checked at c [less than or equal to] 2 x [10.sup.-4] mol dm-3 [32]), while L-16-Y shows an insignificant one (i.e., 3.6% as compared to the effect of 1% Triton X-100 simulating 100% hemolysis [31]). It should be mentioned here that our investigations have been performed at much lower concentrations of the peptides than their minimum inhibitory concentrations (MIC) reported in the literature for various bacteria strains, that is, for N-23-T above 3 x [10.sup.-4] mol [dm.sup.-3] [32], for L-16-Y in the range of 2.5 x [10.sup.-5]-1 x [10.sup.-4] mol [dm.sup.-3] [31, 32], and for E-5-K of ca. 5 x [10.sup.-6] mol [dm.sup.-3] [26].

For the DPPG/N-23-T system, the [DELTA][PI] effect evaluated from the compression isotherms is also notably greater than that of the stationary penetration, in particular, in the range of [[PI].sub.init] < 30 mN [m.sup.-1]. On the other hand, the corresponding [DELTA][DELTA]V effect shows mostly positive in sign (i.e., below 250 mV, Figure 7(b)), while that evaluated from the compression isotherms is close to -20 mV, within almost entire range of [[PI].sub.init] > 3 mN [m.sup.-1] (Figure 3). The stationary penetration results suggest that N-23-T exerts an orienting effect on DPPG monolayer, while the compression isotherms imply a slight disorienting effect in the range of [[PI].sub.init] > 3 mN [m.sup.-1]. It should be emphasized here that the two type experiments match reverse processes, as mentioned in Section 3.1. Results of the stationary penetration (own and the literature ones [47, 48]) indicate that stationary penetration in different lipid-peptide systems reaches the equilibrium after a time of hours. For this reason, one may presume that the reverse process (squeezing out of the monolayer) cannot reach the penetration equilibrium under the compression conditions usually used. This view is supported by the results [86] obtained for mixed monolayers of [beta]-casein with phosphocholines (DPPC, DMPC, or DSPC) which show a strong dependence of the [PI]-A isotherm on equilibration time of a gaseous lipid film spread on subphase containing the peptide.

In conclusion, comparison between the penetration effects obtained by us from the two type experiments indicates that the effects measured upon monolayer compression correspond to a state of supersaturation of the monolayer with the penetrant and, simultaneously, to under-equilibrium orientation of the mixed monolayer. It should be stressed here that the [DELTA][PI] effects calculated from the compression isotherms do not show the propensity of N-23-T for discriminating between negative and neutral lipid monolayers, while the stationary penetration experiments do. It is worth of mentioning here the insertion experiments (the [DELTA]A/A versus t measurements) reported in [77] for penetration of the LL37 peptide into DPPC and DPPG monolayers which amply demonstrate the lipid head group discrimination by the LL37 while the [PI]-A isotherms do not reveal it. Indeed, the stationary penetration results are in accord with series of the literature reports on other AMPs [2, 5-21] which indicate their relatively strong interactions with phosphoglycerol groups in contrast to net neutral phosphocholine groups.

3.6. Stationary Penetration Effects as a Function of Peptide Concentration. The [DELTA][PI] effects of penetration of the three peptides, N-23-T, L-16-Y, and E-5-K, to DPPC and DPPG monolayers are compared in Figure 8, as a function of logarithm of the penetrant's concentration, at [[PI].sub.init] close to 30 mN [m.sup.-1].

One may notice the common linear [DELTA][PI] versus log c dependency for penetration of the three peptides to DPPC monolayer which indicates the nonspecific interactions which probably occur through hydration shells. Such systems are describable with the Langmuir-Szyszkowski equation as discussed in relation to penetration of soluble amphiphiles to insoluble monolayers [63, 64]. Interestingly, the peptide-DPPC interactions are changing from slightly repulsive to slightly attractive ones with increasing the peptide's concentration above 3 x [10.sup.-6] mol [dm.sup.-1]. Since they do not correlate with structure of the peptides, nor with their charge, they may occur through the hydration shells of phosphocholine groups and of peptide in the subsurface region.

On the other hand, the [DELTA][PI] versus log c dependencies measured for stationary penetration of L-16-Y and E-5-K peptides into DPPG monolayer show distinctly different nonlinear shape, indicating the specific peptide-lipid interactions (Figure 8). It is worth emphasizing here that penetration of E-5-K into DPPG monolayers results in a slight negative [DELTA][PI] effect, within the entire investigated concentration range (Figure 8). This indicates the repulsive E-5-K/DPPG monolayer interactions which suggest a negative charge of E-5-K under the experimental conditions. A negative charge of E-5-K is also suggested by negative values of the [DELTA]V at the air/solution interface (cf. Section 3.1). According to theoretical prediction of IEP of E-5-K (cf. Table 1), this peptide should adopt a slight positive charge at pH ca. 5.6. On the other hand, the net charge versus pH dependence (calculated using the "Peptide Property Calculator" of CS Bio Co.) indicates that E-5-K is neutral in the pH range of 5.5-8. The above inconsistencies maybe ascribed to several reasons. First, there are some limitations in calculation of peptide's IEP owing to uncertainty as to pK values of some aminoacids which are regarded as independent for the calculation. For the above, IEP is usually calculated with the accuracy of [+ or -] 0.5. Secondly, the actual pH at air/aqueous interface may essentially differ from that in the solution bulk. Taking the above in mind, the net charge of E-5-K under the conditions used may actually be slightly negative. On the other hand, the [DELTA][DELTA]V effect produced by penetration of E-5-K into DPPC or DPPG monolayers (results not shown) was positive in sign, ranging from 50 to 300 mV. As was discussed for the positively charged peptides, sign of the [DELTA][DELTA]V effect did not show a direct correlation with magnitude of the peptide charge; therefore, the [DELTA][DELTA]V effect is primarily explained by us in terms of orienting the lipid. From this point of view, the relatively short E-5-K peptide, showing repulsive interactions with DPPG monolayer, may exert an orienting effect on it.

The processes investigated herein may be interpreted according to the first steps of the "carpet mechanism", discussed in [2, 8, 9,11-21] in relation to penetration of AMPs into phospholipid bilayers. At the first step, the penetrant binds to the matrix formed by the phospholipid head groups, not entering the acyl chains region. As it was shown by FTIR investigations, at a low peptide/lipid ratio, [alpha]-helical and [beta]-sheet peptides orient parallel with their molecular axis towards the membrane's outer surface. When the ratio increases, the peptide begins to orientate in the membrane [1, 11, 13]. As was recently reported [87, 88], some AMPs possessing a hydrophobicity gradient along the [alpha]-helical long axis may penetrate the acyl chains region at a shallow angle, between 30[degrees] and 60[degrees]. The above mentioned stages may occur in the penetrated DPPG monolayer.

3.7. Long-Time Courses of Penetration, [PI] versus t and [DELTA]V versus t. Figures 9(a) and 9(b) show representative [PI]-t and [DELTA]V-t courses measured during ca. 10 hours of stationary penetration of L-16-Y to DPPG monolayer at different peptide's concentrations.

These results supply some essential information. First, the penetration equilibrium in DPPG monolayer is not established in real experiment time of 60 min, probably owing to a slow conformational equilibrium within the penetrated monolayer. Secondly, the long-time [PI]-t courses registered for the DPPG/L-16-Y system show non monotonic changes after 10-130 min of the contact (Figure 9(a)). They were revealed most distinctly at the highest peptide's concentration, 1 x [10.sup.-5] mol [dm.sup.-3] (Figure 9(a)). These results suggest that the preceding peptide penetration into DPPG monolayer induces a 2D phase transition. In contrast, no non monotonic [PI]-t changes were observed during penetration of the peptides (L-16-Y and N-23-T) into DpPc monolayer (results not shown). This implies that only sufficiently strong peptide-lipid interactions (such as in case of DPPG monolayer) may induce 2D phase transitions during the proceeding penetration.

It should be stressed here that the Thi courses illustrated in Figure 9(a) start at the [[PI].sub.init] close to 30 mN [m.sup.-1]; however, because of dependency of the [DELTA][PI] effect on the peptide's concentration, the non monotonic changes fall at different n values, between 31 and 38 mN [m.sup.-1]. This range coincides well with the upper limit of the wide [C.sup.-1.sub.s] versus n minimum found for DPPG monolayer on the subphase containing N-23-T (insert of Figure 1(b)), which may be ascribed to transformation of the peptide perturbed lipid domains into LC-DPPG domains, as a result of expulsing the penetrant to the subphase.

The corresponding long-time [DELTA]V-t changes driven by the peptides penetration to DPPC or DPPG monolayers did not show discontinuities. The [DELTA]V-t changes measured during the time period of ca. 10 hours exceed by several times those observed during the monolayer compression (cf. Figures 1(b) and 9(b)). The descending [DELTA]V-t courses indicate progressive disorientation of phospholipid monolayer which may be the result of increasing the penetration depth. For the lowest peptide's concentrations, 1 x [10.sup.-6] and 2 x [10.sup.-6] mol [dm.sup.-3], a local [DELTA]V-t maximum was revealed (Figure 9(b)) indicating that, during the penetration process, the monolayer transfers throughout the relatively highest degree of ordering (ascribed by us to the best structural fitting of the peptide's and the lipid's orientations in the monolayer).

It should be mentioned here those the [PI]-t changes observed by us for the DPPG/L-16-Y system (Figure 9(a)) which show analogy to that described by Vollhardt and Fainerman [63] for penetration of [beta]-lactoglobulin or [beta]-casein to DPPC monolayer, and by Zhao and coworkers [89, 90]--for penetration of [beta]-lactoglobulin to DPPC monolayer. The above mentioned authors combined observation of [PI]-t changes during the proceeding penetration (during 500 min) with periodically taken BAM and GIXD measurements. These investigations proved no specific interactions between DPPC molecules and [beta]-lactoglobulin, or [beta]-casein, which is in accord with our results for the milk-derived peptides. The above mentioned authors explained the noncontinuous [PI]-t change to LE/LC transition induced in DPPC monolayer by the penetrant (number and magnitude of domains observed with the BAM technique were notably dependent on initial density of DPPC monolayer). It is worth of mentioning here that similar long-time [PI]-t changes have been recently reported for stationary penetration of three peptides derived from human [beta]-defensin to POPE-POPG (7: 3) monolayers [91].

4. Conclusions

Penetration of the positively charged antimicrobial, milkderived peptides (N-23-T and L-16-Y) into DPPG monolayer, under stationary diffusion conditions, revealed nonlinear profiles of surface pressure, [DELTA][PI] versus [[PI].sub.init], and electric surface potential, [DELTA][DELTA]V versus [[PI].sub.init]--the profiles transferring throughout a maximum at the [[PI].sub.init] of ca. 24mN [m.sup.-1], consistently. Quite distinctly different [DELTA][PI] versus [[PI].sub.init] profiles were obtained for stationary penetration of the peptides into DPPC monolayer--they reach a minimum/plateau at the [[PI].sub.init] > 30m N [m.sup.-1]. On the other hand, the [DELTA][PI] effects evaluated by comparing the compression isotherms on pure water and N-23-T containing subphase are found much greater as compared to those measured under stationary diffusion conditions, in particular, for penetration into DPPC monolayer. In parallel, the [DELTA][DELTA]V effects found from the compression isotherms are much less as compared to those measured upon the stationary penetration. What is more, the compression isotherms did not reveal such a great difference in affinity of lactophoricin-I for DPPG and DPPC monolayers, as it was found from the stationary penetration results. Comparison between our results obtained for lactophoricin-I from the two type experiments indicates that the [DELTA][PI] and [DELTA][DELTA]V effects measured upon compression of the penetrated monolayers (DPPC or DPPG) are much far from the equilibrium, both with respect to amount of the penetrant (which shows supersaturation) and to orientation of the monolayer (which shows an under-equilibrium orientation during compression). In fact, the only results obtained from the stationary penetration experiments are in accord with selective penetration of most antimicrobial peptides (AMPs) into negatively charged microbial membranes, as found in vitro. The principal conclusion of these experiments is that monolayer model of biomembrane when investigated under stationary diffusion conditions supplies results relevant to biological systems while the compression isotherms have to be interpreted with great caution.

The long-time [PI]-t courses (for ca. 10 hours) indicate that equilibrium of the penetration processes establishes after a time of hours, depending on the peptide/lipid ratio. This may be owing to a slow orientation/conformation change of the peptides associated with the lipid film. The [PI]-t courses measured during penetration of L-16-Y into DPPG monolayer show non continuous changes, notably dependent on the peptide's concentration. They indicate that the penetration process into DPPG monolayer induces 2D phase transitions driven by the sufficiently strong peptide-lipid interactions. No discontinuous changes were revealed during stationary penetration of the peptides into DPPC monolayer which is ascribed to the insignificant, repulsive peptide-DPPC interactions.


The Authors thank Dr. Sylvie Campagna from Universite de Montpellier, Centre de Biochimie Structurale, France, for supplying the milk-derived peptides synthetized by her. Two of the authors (Wanda Barzyk and Katarzyna WicclawCzapla) acknowledge a 3-month fellowship from Universite Henri Poincare, Nancy, France.


[1] M. Zasloff, "Antimicrobial peptides of multicellular organisms," Nature, vol. 415, pp. 389-395, 2002.

[2] A. Giuliani, G. Pirri, and S. F. Nicoletto, "Antimicrobial peptides: an overview of a promising class of therapeutics," Central European Journal of Biology, vol. 2, no. 1, pp. 1-33, 2007

[3] G. Wang, X. Li, and Z. Wang, "APD2: the updated antimicrobial peptide database and its application in peptide design," Nucleic Acids Research, vol. 37, supplement 1, pp. D933-D937, 2009.

[4] D. W. Hoskin and A. Ramamoorthy, "Studies on anticancer activities of antimicrobial peptides," Biochimica et Biophysica Acta, vol. 1778, no. 2, pp. 357-375, 2008.

[5] K. Matsuzaki, "Control of cell selectivity of antimicrobial peptides," Biochimica et Biophysica Acta, vol. 1788, no. 8, pp. 1687-1692, 2009.

[6] K. Matsuzaki, K.-I. Sugishita, N. Fujii, and K. Miyajima, "Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2," Biochemistry, vol. 34, no. 10, pp. 3423-3429, 1995.

[7] R. E. W. Hancock and H.-G. Sahl, "Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies," Nature Biotechnology, vol. 24, no. 12, pp. 1551-1557, 2006.

[8] K. Lohner, "New strategies for novel antibiotics: peptides targeting bacterial cell membranes," General Physiology and Biophysics, vol. 28, no. 2, pp. 105-116, 2009.

[9] K. Lohner and F. Prossnigg, "Biological activity and structural aspects of PGLa interaction with membrane mimetic systems," Biochimica et Biophysica Acta, vol. 1788, no. 8, pp. 1656-1666, 2009.

[10] N. Y. Yount, A. S. Bayer, Y. Q. Xiong, and M. R. Yeaman, "Advances in antimicrobial peptide immunobiology," Biopolymers, vol. 84, no. 5, pp. 435-458, 2006.

[11] M. R. Yeaman and N. Y. Yount, "Mechanisms of antimicrobial peptide action and resistance," Pharmacological Reviews, vol. 55, no. 1, pp. 27-55, 2003.

[12] H. W Huang, "Molecular mechanism of antimicrobial peptides: the origin of cooperativity," Biochimica et Biophysica Acta, vol. 1758, no. 9, pp. 1292-1302, 2006.

[13] H. Sato and J. B. Feix, "Peptide-membrane interactions and mechanisms of membrane destruction by amphipathic ahelical antimicrobial peptides," Biochimica et Biophysica Acta, vol. 1758, no. 9, pp. 1245-1256, 2006.

[14] K. A. Brogden, "Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?" Nature Reviews Microbiology, vol. 3, no. 3, pp. 238-250, 2005.

[15] N. Papo and Y. Shai, "Can we predict biological activity of antimicrobial peptides from their interactions with model phospholipid membranes?" Peptides, vol. 24, no. 11, pp. 16931703, 2003.

[16] Y. Shai, "Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by [alpha]-helical antimicrobial and cell non-selective membrane-lytic peptides," Biochimica et Biophysica Acta, vol. 1462, no. 1-2, pp. 55-70, 1999.

[17] N. Sitaram and R. Nagaraj, "The therapeutic potential of host-defense antimicrobial peptides," Current Drug Targets, vol. 3, no. 3, pp. 259-267, 2002.

[18] N. Sitaram and R. Nagaraj, "Host-defense antimicrobial peptides: importance of structure for activity," Current Pharmaceutical Design, vol. 8, no. 9, pp. 727-742, 2002.

[19] N. Sitaram and R. Nagaraj, "Interaction of antimicrobial peptides with biological and model membranes: structural and charge requirements for activity," Biochimica et Biophysica Acta, vol. 1462, no. 1-2, pp. 29-54, 1999.

[20] S. E. Blondelle, K. Lohner, and M.-I. Aguilar, "Lipid-induced conformation and lipid-binding properties of cytolytic and antimicrobial peptides: determination and biological specificity," Biochimica et Biophysica Acta, vol. 1462, no. 1-2, pp. 89-108, 1999.

[21] R. M. Epand and H. J. Vogel, "Diversity of antimicrobial peptides and their mechanisms of action," Biochimica et Biophysica Acta, vol. 1462, no. 1-2, pp. 11-28, 1999.

[22] E. F. Haney, H. N. Hunter, K. Matsuzaki, and H. J. Vogel, "Solution NMR studies of amphibian antimicrobial peptides: linking structure to function?" Biochimica et Biophysica Acta, vol. 1788, no. 8, pp. 1639-1655, 2009.

[23] S. Thennarasu, R. Huang, D.-K. Lee et al., "Limiting an antimicrobial peptide to the lipid-water interface enhances its bacterial membrane selectivity: a case study of MSI-367," Biochemistry, vol. 49, no. 50, pp. 10595-10605, 2010.

[24] B. Hernandez-Ledesma, I. Recio, and L. Amigo, "[beta]-Lactoglobulin as source of bioactive peptides," Amino Acids, vol. 35, no. 2, pp. 257-265, 2008.

[25] A. Pellegrini, "Antimicrobial peptides from food proteins," Current Pharmaceutical Design, vol. 9, no. 16, pp. 1225-1238, 2003.

[26] A. Pellegrini, U. Thomas, N. Bramaz, P. Hunziker, and R. Von Fellenberg, "Isolation and identification of three bactericidal domains in the bovine [alpha]-lactalbumin molecule," Biochimica et Biophysica Acta, vol. 1426, no. 3, pp. 439-448,1999.

[27] I. Lapez-Expasito, L. Amigo, and I. Recio, "Identification of the initial binding sites of [alpha]s2-casein f(183-207) and effect on bacterial membranes and cell morphology," Biochimica et Biophysica Acta, vol. 1778, no. 10, pp. 2444-2449, 2008.

[28] I. Recio and I. Lapez-Exposito, "Protective effect of milk peptides: antibacterial and antitumor properties," Advances in Experimental Medicine and Biology, vol. 606, pp. 271-293,2008.

[29] I. Lapez Expasito and I. Recio, "Antibacterial activity of peptides and folding variants from milk proteins," International Dairy Journal, vol. 16, no. 11, pp. 1294-1305, 2006.

[30] I. Lapez-Expasito, F. Minervini, L. Amigo, and I. Recio, "Identification of antibacterial peptides from bovine [kappa]-casein," Journal of Food Protection, vol. 69, no. 12, pp. 2992-2997, 2006.

[31] I. Recio and S. Visser, "Identification of two distinct antibacterial domains within the sequence of bovine [alpha](s2)-casein," Biochimica et Biophysica Acta, vol. 1428, no. 2-3, pp. 314-326, 1999.

[32] S. Campagna, A.-G. Mathot, Y. Fleury, J.-M. Girardet, and J.L. Gaillard, "Antibacterial activity of lactophoricin, a synthetic 23-residues peptide derived from the sequence of bovine milk component-3 of proteose peptone," Journal of Dairy Science,vo\. 87, no. 6, pp. 1621-1626, 2004.

[33] S. Campagna, P. Cosette, G. Molle, and J.-L. Gaillard, "Evidence for membrane affinity of the C-terminal domain of bovine milk PP3 component," Biochimica et Biophysica Acta, vol. 1513, no. 2, pp. 217-222, 2001.

[34] S. Campagna, N. Van Mau, F. Heitz, G. Humbert, and J.-L. Gaillard, "Specific interaction between anionic phospholipids and milk bovine component PP3 and its 119-135 C-terminal fragment," Colloids and Surfaces B, vol. 13, no. 6, pp. 299-309, 1999.

[35] N. Benkerroum, "Antimicrobial peptides generated from milk proteins: a survey and prospects for application in the food industry. A review," International Journal of Dairy Technology, vol. 63, no. 3, pp. 320-338, 2010.

[36] M. Arseneault, S. Bedard, M. Boulet-Audet, and M. Pezolet, "Study of the interaction of lactoferricin B with phospholipid monolayers and bilayers," Langmuir, vol. 26, no. 5, pp. 34683478, 2010.

[37] D. J. Schibli, P. M. Hwang, and H. J. Vogel, "The structure of the antimicrobial active center of lactoferricin B bound to sodium dodecyl sulfate micelles," FEBS Letters, vol. 446, no. 2-3, pp. 213-217, 1999.

[38] S. Nakai, J. C. K. Chan, E. C. Y. Li-Chan, J. Dou, and M. Ogawa, "Homology similarity analysis of sequences of lactoferricin and its derivatives," Journal of Agricultural and Food Chemistry, vol. 51, no. 5, pp. 1215-1223, 2003.

[39] J. L. Gifford, H. N. Hunter, and H. J. Vogel, "Lactoferricin: a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties," Cellular and Molecular Life Sciences, vol. 62, no. 22, pp. 2588-2598, 2005.

[40] T.-J. Park, J.-S. Kim, S.-S. Choi, and Y. Kim, "Cloning, expression, isotope labeling, purification, and characterization of bovine antimicrobial peptide, lactophoricin in Escherichia coli," Protein Expression and Purification, vol. 65, no. 1, pp. 23-29, 2009.

[41] T.-J. Park, J.-S. Kim, H.-C. Ahn, and Y. Kim, "Solution and solid-state NMR structural studies of antimicrobial peptides LPcin-I and LPcin-II," Biophysical Journal, vol. 101, no. 5, pp. 1193-1201, 2011.

[42] H. Brockman, "Lipid monolayers: why use half a membrane to characterize protein-membrane interactions?" Current Opinion in Structural Biology, vol. 9, no. 4, pp. 438-443, 1999.

[43] G. Brezezinski and H. Mohwald, "Langmuir monolayers to study interactions at model membrane surfaces," Advances in Colloid and Interface Science, vol. 100-102, pp. 563-584, 2003.

[44] R. Volinsky, S. Kolusheva, A. Berman, and R. Jelinek, "Investigations of antimicrobial peptides in planar film systems," Biochimica et Biophysica Acta, vol. 1758, no. 9, pp. 1393-1407, 2006.

[45] R. Volinsky, S. Kolusheva, A. Berman, and R. Jelinek, "Microscopic visualization of alamethicin incorporation into model membrane monolayers," Langmuir, vol. 20, no. 25, pp. 1108411091, 2004.

[46] D. Marsh, "Lateral pressure in membranes," Biochimica et Biophysica Acta, vol. 1286, no. 3, pp. 183-223,1996.

[47] P. Calvez, S. Bussieres, E. D. Eric Demers, and C. Salesse, "Parameters modulating the maximum insertion pressure of proteins and peptides in lipid monolayers," Biochimie, vol. 91, no. 6, pp. 718-733, 2009.

[48] R. Maget-Dana, "The monolayer technique: a potent tool for studying the interfacial properties of antimicrobial and membrane-lytic peptides and their interactions with lipid membranes," Biochimica et Biophysica Acta, vol. 1462, no. 1-2, pp. 109-140, 1999.

[49] R. Maget-Dana, C. Hetru, and M. Ptak, "Surface activity of the insect defensin A and its interactions with lipids in mixed monolayers," Thin Solid Films, vol. 284-285, pp. 841-844, 1996.

[50] J.-P. Mattila, K. Sabatini, and P. K. J. Kinnunen, "Oxidized phospholipids as potential molecular targets for antimicrobial peptides," Biochimica et Biophysica Acta, vol. 1778, no. 10, pp. 2041-2050, 2008.

[51] H. Zhao, R. Sood, A. Jutila et al., "Interaction of the antimicrobial peptide pheromone Plantaricin A with model membranes: implications for a novel mechanism of action," Biochimica et Biophysica Acta, vol. 1758, no. 9, pp. 1461-1474, 2006.

[52] F. Reig, P. Sospedra, A. Juve, and L. Rodriguez, "Interaction of a laminin derived peptide with phosphatidyl choline/phosphatidyl glycerol," Talanta, vol. 60, no. 2-3, pp. 591-600, 2003.

[53] N. Rubio, M. Pujol, M. Munoz, M. A. Alsina, I. Haro, and F. Reig, "Physicochemical study of laminin-related peptides," Supramolecular Science, vol. 4, no. 3-4, pp. 449-453, 1997

[54] A. Kouzayha and F. Besson, "GPI-alkaline phosphatase insertion into phosphatidylcholine monolayers: phase behavior and morphology changes," Biochemical and Biophysical Research Communications, vol. 333, no. 4, pp. 1315-1321, 2005.

[55] M. F. Martini and E. A. Disalvo, "Superficially active water in lipid membranes and its influence on the interaction of an aqueous soluble protease," Biochimica et Biophysica Acta, vol. 1768, no. 10, pp. 2541-2548, 2007.

[56] S. Mukhopadhyay and W. Cho, "Interactions of annexin V with phospholipid monolayers," Biochimica et Biophysica Acta, vol. 1279, no. 1, pp. 58-62, 1996.

[57] D. Trommeshauser, S. Krol, L. D. Bergelson, and H.-J. Galla, "The effect of lipid composition and physical state of phospholipid monolayer on the binding and incorporation of a basic amphipathic peptide from the C-terminal region of the HIV envelope protein gp41," Chemistry and Physics of Lipids, vol. 107, no. 1, pp. 83-92, 2000.

[58] K. Weronski, M. A. Busquets, V Girona, and J. Prat, "Influence of lipidation of GBV-C/HGV NS3 (513-522) and (505-514) peptide sequences on its interaction with mono and bilayers," Colloids and Surfaces B, vol. 57, no. 1, pp. 8-16, 2007

[59] F. Reig, A. Juve, P. Sospedra, and L. Rodriguez, "Hydrophobic peptide interactions with phospholipids," Colloids and Surfaces A, vol. 249, no. 1-3, pp. 15-18, 2004.

[60] M. A. Alsina, A. Ortiz, D. Polo, F. Comelles, and F. Reig, "Synthesis and study of molecular interactions between phosphatidyl choline and two laminin derived peptides hydrophobically modified," Journal of Colloid and Interface Science, vol. 294, no. 2, pp. 385-390, 2006.

[61] V Caol, A. Van der Heyden, D. Champmartin, W. Barzyk, P. Rubini, and E. Rogalska, "Interfacial approach to aluminum toxicity: interactions of Al(III) and Pr(III) with model phospholipid bilayer and monolayer membranes," Langmuir, vol. 19, no. 21, pp. 8697-8708, 2003.

[62] J. Minones Jr., J. M. Rodriguez Patino, O. Conde, C. Carrera, and R. Seoane, "The effect of polar groups on structural characteristics of phospholipid monolayers spread at the airwater interface," Colloids and Surfaces A, vol. 203, no. 1-3, pp. 273-286, 2002.

[63] D. Vollhardt and V B. Fainerman, "Penetration of dissolved amphiphiles into two-dimensional aggregating lipid monolayers," Advances in Colloid and Interface Science, vol. 86, no. 1, pp. 103-151, 2000.

[64] V. B. Fainerman and D. Vollhardt, "Penetration of Langmuir monolayers by soluble amphiphilic molecules," Langmuir, vol. 15, no. 5, pp. 1784-1790, 1999.

[65] J. Minones Jr., P. Dynarowicz-h>tka, J. Minones, J. M. Rodriguez Patino, and E. Iribarnegaray, "Orientational changes in dipalmitoyl phosphatidyl glycerol Langmuir monolayers," Journal of Colloid and Interface Science, vol. 265, no. 2, pp. 380-385, 2003.

[66] E. Saint Martin, O. Konovalov, and J. Daillant, "Studies of phospholipid monolayer at liquid/liquid interface in presence of an antimicrobial peptide," Thin Solid Films, vol. 515, no. 14, pp. 5687-5690, 2007.

[67] D. Vollhardt, V. B. Fainerman, and S. Siegel, "Thermodynamic and textural characterization of DPPG phospholipid monolayers," Journal of Physical Chemistry B, vol. 104, no. 17, pp. 4115-4121, 2000.

[68] P. Garidel and A. Blume, "1,2-Dimyristoyl-sn-glycero-3-phosphoglycerol (DMPG) monolayers: influence of temperature, pH, ionic strength and binding of alkaline earth cations," Chemistry and Physics of Lipids, vol. 138, no. 1-2, pp. 50-59, 2005.

[69] D. Grigoriev, R. Miller, R. Wustneck, N. Wustneck, U. Pison, and H. Mohwald, "A novel method to evaluate the phase transition thermodynamics of Langmuir monolayers. Application to DPPG monolayers affected by subphase composition," Journal of Physical Chemistry B, vol. 107, no. 51, pp. 14283-14288, 2003.

[70] D. Grigoriev, R. Krustev, R. Miller, and U. Pison, "Effect of monovalent ions on the monolayers phase behavior of the charged lipid DPPG," Journal of Physical Chemistry B, vol. 103, no. 6, pp. 1013-1018, 1999.

[71] A. Dicko, H. Bourque, and M. Pezolet, "Study by infrared spectroscopy of the conformation of dipalmitoylphosphatidyl-glycerol monolayers at the air-water interface and transferred on solid substrates," Chemistry and Physics of Lipids, vol. 96, no. 1-2, pp. 125-139, 1998.

[72] H. Nakahara, S. Nakamura, S. Lee, G. Sugihara, and O. Shibata, "Influence of a new amphiphilic peptide with phospholipid monolayers at the air-water interface," Colloids and Surfaces A, vol. 270-271, no. 1-3, pp. 52-60, 2005.

[73] A. Bellomio, R. G. Oliveira, B. Maggio, and R. D. Morero, "Penetration and interactions of the antimicrobial peptide, microcin J25, into uncharged phospholipid monolayers," Journal of Colloid and Interface Science, vol. 285, no. 1, pp. 118-124, 2005.

[74] E. E. Ambroggio, F. Separovic, J. Bowie, and G. D. Fidelio, "Surface behaviour and peptide-lipid interactions of the antibiotic peptides, Maculatin and Citropin," Biochimica etBiophysica Acta, vol. 1664, no. 1, pp. 31-37, 2004.

[75] W. Barzyk, S. Campagna, K. Wieclaw, B. Korchowiec, and E. Rogalska, "The affinity of two antimicrobial peptides derived from bovine milkproteins for model lipid membranes," Colloids and Surfaces A, vol. 343, no. 1-3, pp. 104-110, 2009.

[76] F. Neville, O. Konovalov, and D. Gidalevitz, "A comparative study on the interactions of SMAP-29 with lipid monolayers," Biochimica etBiophysica Acta, vol. 1798, pp. 851-860, 2010.

[77] F. Neville, M. Cahuzac, O. Konovalov et al., "Lipid headgroup discrimination by antimicrobial peptide LL-37: insight into mechanism of action," Biophysical Journal, vol. 90, pp. 1275-1287, 2006.

[78] D. M. Taylor, "Developments in the theoretical modelling and experimental measurement of the surface potential of condensed monolayers," Advances in Colloid and Interface Science, vol. 87, no. 2-3, pp. 183-203, 2000.

[79] P. Dynarowicz, "Recent developments in the modeling of the monolayers structure at the water/air interface," Advances in Colloid and Interface Science, vol. 45, pp. 215-241,1993.

[80] V. Vogel and D. Mobius, "Local surface potentials and electric dipole moments of lipid monolayers: contributions of the water/lipid and the lipid/air interfaces," Journal of Colloid And Interface Science, vol. 126, no. 2, pp. 408-420, 1988.

[81] J. T. Davies and E. K. Rideal, Interfacial Phenomena, Academic Press, New York, NY, USA, 1963.

[82] D. Vollhardt and V. B. Fainerman, "Progress in characterization of Langmuir monolayers by consideration of compressibility," Advances in Colloid and Interface Science, vol. 127, no. 2, pp. 8397, 2006.

[83] W. Barzyk and J. Vuorinen, "Application of the vibrating plate (VP) technique to measuring electric surface potential, [DELTA]V, of solutions; the flow cell for simultaneous measurement of the [Deltfa]V and the surface pressure, [PI]" Colloids and Surfaces A, vol. 385, no. 1-3, pp. 1-10, 2011.

[84] G. T. Barnes, "The equilibrium penetration of monolayers. Is equilibrium really established?" Colloids and Surfaces A, vol. 190, no. 1-2, pp. 145-151, 2001.

[85] G. T. Barnes, G. A. Lawrie, and K. Walker, "Equilibrium penetration of monolayers. 9. A comparison of treatments for analyzing surface-pressure-area data," Langmuir, vol. 14, no. 8, pp. 2148-2153, 1998.

[86] J. B. Li, J. Krogel, A. V. Makiewski, V. B. Finerman, R. Miller, and H. Mohwald, "A study of mixed phospholipid/[beta]-casein monolayers at the water/air interface," Colloids and Surfaces A, vol. 142, pp. 355-360, 1998.

[87] S. R. Dennison, L. H. G. Morton, F. Harris, and D. A. Phoenix, "The impact of membrane lipid composition on antimicrobial function of an [alpha]-helical peptide," Chemistry and Physics of Lipids, vol. 151, no. 2, pp. 92-102, 2008.

[88] S. R. Dennison, F. Harris, and D. A. Phoenix, "Are oblique orientated [alpha]-helices used by antimicrobial peptides for membrane invasion?" Protein and Peptide Letters, vol. 12, no. 1, pp. 27-29, 2005.

[89] J. Zhao, D. Vollhardt, G. Brezesinski et al., "Effect of protein penetration into phospholipid monolayers: morphology and structure," Colloids and Surfaces A, vol. 171, no. 1-3, pp. 175-184, 2000.

[90] V. B. Fainerman, J. Zhao, D. Vollhardt, A. V. Makievski, and J. B. Li, "Dynamics of [beta]-Lactoglobulin penetration into Langmuir monolayers of 2D condensating phospholipid," Journal of Physical Chemistry B, vol. 103, no. 42, pp. 8998-9007, 1999.

[91] V. Krishnakumari and R. Nagaraj, "Interaction of antibacterial peptides spanning the carboxy-terminal region of human [beta]-defensins 1-3 with phospholipids at the air-water interface and inner membrane of E. coli," Peptides,vol. 29, no. 1,pp. 7-14, 2008.

Wanda Barzyk, (1) Ewa Rogalska, (2) and Katarzyna Wicclaw-Czapla (3)

(1) Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Niezapominajek Street 8, 30-239 Cracow, Poland

(2) UMR 7565 CNRS SRSMC, Universite de Lorraine, Faculte des Sciences et Technologies, BP 239, 54506 Vandoeuvre-les-Nancy Cedex, France

(3) Department of Physical Chemistry and Electrochemistry, Faculty of Chemistry, Jagiellonian University, Ingardena 3, 30-060 Cracow, Poland

Correspondence should be addressed to Wanda Barzyk;

Received 27 June 2013; Revised 27 August 2013; Accepted 27 August 2013

Academic Editor: Vladimir Uversky

TABLE 1: Data on structure and antimicrobial activities
of the investigated peptides.

Name               Origin/molecular mass      Amino acid sequence

E-5-K             Residues 1-5 of [alpha]-       H,N-EQLTK-COOH
                   lactalbumin/689 g/mol

L-16-Y              Residues 164-179 of      EEN-LKKISQRYQKFALPQY-
                  [alpha]-casein/2011.4 Da            COOH

N-23-T or           Residues 113-135 of           [H.sub.2]N-
Lactophoricin-I    bovine component-3 of     NTVKETIKYLKSLFSHAFEWKT
(LPcin-I)             proteose peptone               -COOH
                       (PP3)/2683 Da

Name              Total net        Total          No. of
                  charge at     hydrophobic    hydrophobic
                   pH 7/pH     ratio [%] (a)   residues on
                   5.6(a-e)                      molecule
                                               residues (a)

E-5-K             O/ca. 0(b)        20             0/1

L-16-Y              +4/+4           31             0/5

N-23-T or          +2.1/+3          39             9/9

Name                 Secondary          IEP       Antimicrobial and
                     structure       predicted   hemolytic activities

E-5-K              Random coil or    6.1 [26]       G. + bacteria;
                     quasi-pure      6.9 [35]    Not fungicidal [26]
                      (c) [26]

L-16-Y            Random coil [35]   10.5 [35]      G. + and G. -
                  or [alpha]-helix                bacteria; Slightly
                   (c,e) [31,35]                    hemolytic [31]

N-23-T or          [alpha]-helix     9.4 [33]    Mostly against G. +
Lactophoricin-I   (c) [32], random    9.95(e)       bacteria, not
(LPcin-I)         in solutions and                  hemolytic [32]
                    50% helical
                     content in
                     LPC(d) and
                  SDS(d) micelles
                  [33], monomer in
                  [H.sub.2]0 [32]

(a) Values predicted using the "APD2: Antimicrobial Peptide Predictor"
software, available at [3].

(b) According to the theoretical prediction of IEP of E-5-K
(consistent with [26, 35]), this peptide should adopt a slightly
positive charge at the used pH ca. 5.6; however, the penetration
results (Figure 8) indicate a slight negative charge of E-5-K,
under the experimental conditions.

(c) Derived according to the secondary structure algorithm [31].

(d) LPC denotes L-[alpha]-lysophosphatidylcholine, and
SDS denotes sodium dodecyl sulphate.

(e) The value is predicted using the "Peptide Property Calculator"
of CS Bio Co. software available at
(used also in [35]).
COPYRIGHT 2014 Hindawi Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Research Article
Author:Barzyk, Wanda; Rogalska, Ewa; Wieclaw-Czapla, Katarzyna
Publication:Biochemistry Research International
Article Type:Report
Date:Jan 1, 2014
Previous Article:Microbial tyrosinases: promising enzymes for pharmaceutical, food bioprocessing, and environmental industry.
Next Article:Adaptation of sonication-assisted matrix solid phase dispersion of tissues for the subsequent extraction of polycyclic aromatic hydrocarbons from...

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |